SLNO: Soleno Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Soleno Therapeutics Inc (SLNO).
$1.94B Market Cap.
SLNO Market Cap. (MRY)
SLNO Shares Outstanding (MRY)
SLNO Assets (MRY)
Total Assets
$330.97M
Total Liabilities
$85.86M
Total Investments
$230.72M
SLNO Income (MRY)
Revenue
$0
Net Income
-$175.85M
Operating Expense
$184.43M
SLNO Cash Flow (MRY)
CF Operations
-$69.10M
CF Investing
-$225.68M
CF Financing
$213.03M
SLNO Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $330,972,000 (83.17%) | $180,691,000 (581.93%) | $26,497,000 (-25.47%) | $35,553,000 (-45.29%) |
Assets Current | $293,889,000 (71.51%) | $171,358,000 (995.15%) | $15,647,000 (-30.22%) | $22,422,000 (-55.37%) |
Assets Non-Current | $37,083,000 (297.33%) | $9,333,000 (-13.98%) | $10,850,000 (-17.37%) | $13,131,000 (-10.91%) |
Goodwill & Intangible Assets | $6,805,000 (-22.22%) | $8,749,000 (-18.18%) | $10,693,000 (-15.38%) | $12,637,000 (-13.33%) |
Shareholders Equity | $245,113,000 (55.62%) | $157,507,000 (1422.10%) | $10,348,000 (-41.84%) | $17,793,000 (-60.93%) |
Property Plant & Equipment Net | $2,984,000 (612.17%) | $419,000 (166.88%) | $157,000 (-65.42%) | $454,000 (187.34%) |
Cash & Equivalents | $87,928,000 (-48.18%) | $169,681,000 (1062.04%) | $14,602,000 (-31.46%) | $21,304,000 (-56.72%) |
Accumulated Other Comprehensive Income | $361,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $230,720,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $203,509,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $27,211,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $8,882,000 (182.06%) | $3,149,000 (77.21%) | $1,777,000 (-45.39%) | $3,254,000 (-6.74%) |
Accumulated Retained Earnings (Deficit) | -$452,260,000 (-63.62%) | -$276,410,000 (-16.42%) | -$237,422,000 (-11.28%) | -$213,355,000 (-16.94%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $52,826,000 (13008.19%) | $403,000 (160.00%) | $155,000 (-66.08%) | $457,000 (228.78%) |
Debt Current | $526,000 (92.67%) | $273,000 (76.13%) | $155,000 (-45.04%) | $282,000 (102.88%) |
Debt Non-Current | $52,300,000 (40130.77%) | $130,000 (0%) | $0 (0%) | $175,000 (0%) |
Total Liabilities | $85,859,000 (270.34%) | $23,184,000 (43.56%) | $16,149,000 (-9.07%) | $17,760,000 (-8.62%) |
Liabilities Current | $18,747,000 (62.95%) | $11,505,000 (57.32%) | $7,313,000 (-8.67%) | $8,007,000 (-7.09%) |
Liabilities Non-Current | $67,112,000 (474.64%) | $11,679,000 (32.18%) | $8,836,000 (-9.40%) | $9,753,000 (-9.84%) |
SLNO Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $105,861,000 (685.26%) | $13,481,000 (36.95%) | $9,844,000 (-8.90%) | $10,806,000 (23.38%) |
Research & Development Expense | $78,568,000 (211.91%) | $25,189,000 (65.01%) | $15,265,000 (-28.84%) | $21,453,000 (-7.49%) |
Operating Expenses | $184,429,000 (376.93%) | $38,670,000 (54.01%) | $25,109,000 (-22.16%) | $32,259,000 (0.97%) |
Interest Expense | $231,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$175,850,000 (-351.04%) | -$38,988,000 (-62.00%) | -$24,067,000 (22.14%) | -$30,910,000 (-25.45%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$175,850,000 (-351.04%) | -$38,988,000 (-62.00%) | -$24,067,000 (22.14%) | -$30,910,000 (-25.45%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$175,850,000 (-351.04%) | -$38,988,000 (-62.00%) | -$24,067,000 (22.14%) | -$30,910,000 (-25.45%) |
Weighted Average Shares | $40,175,926 (143.61%) | $16,492,132 (96.40%) | $8,397,088 (57.90%) | $5,318,022 (27.39%) |
Weighted Average Shares Diluted | $40,175,926 (143.61%) | $16,492,132 (96.40%) | $8,397,088 (57.90%) | $5,318,022 (27.39%) |
Earning Before Interest & Taxes (EBIT) | -$175,619,000 (-350.44%) | -$38,988,000 (-62.00%) | -$24,067,000 (22.14%) | -$30,910,000 (-25.45%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$184,429,000 (-376.93%) | -$38,670,000 (-54.01%) | -$25,109,000 (22.16%) | -$32,259,000 (-0.97%) |
SLNO Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$225,682,000 (0%) | $0 (0%) | -$13,000 (40.91%) | -$22,000 (-214.29%) |
Net Cash Flow from Financing | $213,025,000 (18.33%) | $180,019,000 (1177.46%) | $14,092,000 (11109.38%) | -$128,000 (-100.24%) |
Net Cash Flow from Operations | -$69,096,000 (-177.05%) | -$24,940,000 (-20.01%) | -$20,781,000 (25.17%) | -$27,770,000 (-10.09%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$81,753,000 (-152.72%) | $155,079,000 (2413.92%) | -$6,702,000 (76.00%) | -$27,920,000 (-198.00%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$225,464,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$218,000 (0%) | $0 (0%) | -$13,000 (40.91%) | -$22,000 (-214.29%) |
Issuance (Repayment) of Debt Securities | $49,888,000 (0%) | $0 (0%) | $0 (0%) | -$8,000 (52.94%) |
Issuance (Purchase) of Equity Shares | $163,137,000 (-9.38%) | $180,019,000 (1176.01%) | $14,108,000 (0%) | $0 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $99,958,000 (1581.38%) | $5,945,000 (134.98%) | $2,530,000 (-22.77%) | $3,276,000 (118.40%) |
Depreciation Amortization & Accretion | $2,431,000 (6.67%) | $2,279,000 (1.11%) | $2,254,000 (0.13%) | $2,251,000 (0.63%) |
SLNO Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -75.30% (5.52%) | -79.70% (40.12%) | -133.10% (-10.92%) | -120.00% (-93.86%) |
Return on Average Assets (ROAA) | -63.90% (-20.79%) | -52.90% (24.21%) | -69.80% (-3.71%) | -67.30% (-69.10%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -84.20% (-126.03%) | 323.50% (-21.84%) | 413.90% (-6.78%) | 444.00% (24.89%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -10.26 (39.82%) | -17.05 (-2371.74%) | -0.69 (34.84%) | -1.06 (78.60%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 7.91 (1.45%) | 7.79 (399.30%) | 1.56 (-15.12%) | 1.84 (-45.49%) |
Debt to Equity Ratio (D/E) | 0.35 (138.10%) | 0.15 (-90.58%) | 1.56 (56.41%) | 1 (133.72%) |
Earnings Per Share (EPS) | -4.38 (-85.59%) | -2.36 (17.77%) | -2.87 (50.60%) | -5.81 (0.68%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -1.73 (-14.09%) | -1.51 (38.93%) | -2.48 (52.62%) | -5.23 (13.53%) |
Book Value Per Share (BVPS) | 6.1 (-36.12%) | 9.55 (675.16%) | 1.23 (-63.18%) | 3.35 (-69.33%) |
Tangible Assets Book Value Per Share (TABVPS) | 8.07 (-22.61%) | 10.43 (453.99%) | 1.88 (-56.32%) | 4.31 (-64.31%) |
Enterprise Value Over EBIT (EV/EBIT) | -11 (63.33%) | -30 (0%) | 0 (0%) | 0 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -10.93 (65.87%) | -32.03 (-20896.10%) | 0.15 (186.52%) | -0.18 (95.92%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 15.68 (5.26%) | 14.89 (595.98%) | 2.14 (-23.57%) | 2.8 (-51.97%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$69,314,000 (-177.92%) | -$24,940,000 (-19.94%) | -$20,794,000 (25.18%) | -$27,792,000 (-10.15%) |
Enterprise Value (EV) | $1,892,744,568 (61.00%) | $1,175,631,918 (35126.32%) | -$3,356,424 (-165.82%) | $5,099,594 (-94.78%) |
Earnings Before Tax (EBT) | -$175,850,000 (-351.04%) | -$38,988,000 (-62.00%) | -$24,067,000 (22.14%) | -$30,910,000 (-25.45%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$173,188,000 (-371.79%) | -$36,709,000 (-68.29%) | -$21,813,000 (23.89%) | -$28,659,000 (-27.93%) |
Invested Capital | $270,318,000 (3157.55%) | -$8,841,000 (-48.44%) | -$5,956,000 (-0.30%) | -$5,938,000 (18.68%) |
Working Capital | $275,142,000 (72.12%) | $159,853,000 (1818.08%) | $8,334,000 (-42.19%) | $14,415,000 (-65.37%) |
Tangible Asset Value | $324,167,000 (88.53%) | $171,942,000 (987.97%) | $15,804,000 (-31.04%) | $22,916,000 (-54.53%) |
Market Capitalization | $1,938,128,568 (57.88%) | $1,227,598,918 (7498.61%) | $16,155,576 (-50.63%) | $32,720,594 (-78.71%) |
Average Equity | $233,488,750 (377.01%) | $48,948,000 (170.74%) | $18,079,250 (-29.79%) | $25,750,250 (-35.31%) |
Average Assets | $275,161,500 (273.46%) | $73,679,500 (113.74%) | $34,470,750 (-24.90%) | $45,900,500 (-25.89%) |
Invested Capital Average | $208,618,250 (1830.77%) | -$12,053,500 (-107.32%) | -$5,814,000 (16.48%) | -$6,961,000 (-0.43%) |
Shares | 43,117,432 (41.37%) | 30,499,352 (273.79%) | 8,159,382 (53.36%) | 5,320,459 (0.24%) |
